To improve the lives of those struggling with Post–Traumatic Stress Disorder (PTSD)
Founded to provide a beacon for those losing hope
GoodCap was created to help those who desperately need better mental healthcare. Over the past ten years, GoodCap co-founder Darryl Hudson, PhD. built strong connections with many military veterans and saw firsthand the sad truth about the mental health treatments they were provided. Many of these veterans struggled with conditions like Post-Traumatic Stress Disorder (PTSD), depression, and anxiety. Even now, patients must try approved pharmaceutical interventions one by one, hoping to find something that works. This long and difficult process can make their pain and suffering worse, leading to further dismay and anger.
The current standard of care does not meet the complex needs of patients
Antidepressants are the current front-line treatment option for those suffering with PTSD, and these drugs lead to remission of the disorder in less than 1/3 of patients as they are designed to solely increase serotonin in the brain, however PTSD patients exhibit a much wider range of symptoms and dysregulated physical markers. Dr. Hudson quickly recognized this broad-symptomology and realized there must be a better way to treat these patients, which quickly became the inspiration for the novel formulations that GoodCap is developing today.
Designed for greater patient access, success, and safety
The GoodCap team believes that we can provide PTSD patients with a much better quality of life. Through our research and real-world observations, we have created a drug designed to address the multitude of PTSD symptoms simultaneously, greatly increasing the probability of relief for patients. Our proprietary formulations of well-known compounds feature anti-inflammatory, neuroprotective, antioxidant, and analgesic properties, each with excellent safety profiles designed to limit adverse events and side effects.